Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
(CH3)3CCOCH2COCF3
CAS Number:
Molecular Weight:
196.17
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
245-211-0
MDL number:
Assay:
98%
Quality Level
assay
98%
refractive index
n20/D 1.407 (lit.)
bp
138-141 °C (lit.)
density
1.129 g/mL at 25 °C (lit.)
functional group
fluoro, ketone
SMILES string
CC(C)(C)C(=O)CC(=O)C(F)(F)F
InChI
1S/C8H11F3O2/c1-7(2,3)5(12)4-6(13)8(9,10)11/h4H2,1-3H3
InChI key
BVPKYBMUQDZTJH-UHFFFAOYSA-N
Gene Information
mouse ... Mtap(66902)
General description
1,1,1-Trifluoro-5,5-dimethyl-2,4-hexanedione (TFDMHD) is a 1,3-diketone. It forms Er(3+) complexes. These complexes shows thermally activated slow relaxation of magnetization under a zero direct-current (DC) field.
Application
1,1,1-Trifluoro-5,5-dimethyl-2,4-hexanedione (TFDMHD) may be used in the synthesis of series of NNO ketoimines bearing trifluoromethyl substituents, via Schiff base condensation. It may be used in the synthesis of octahedral Werner-type cobalt(II) complexes. It was used in the preparation of D2-TFDMHD, by mixing with D2O.
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Conformation, molecular structure, and intramolecular hydrogen bonding of 1, 1, 1-trifluoro-5, 5-dimethyl-2, 4-hexanedione.
Vakili M, et al.
Journal of Molecular Structure, 1021, 102-111 (2012)
M Ramos Silva et al.
Dalton transactions (Cambridge, England : 2003), 44(3), 1264-1272 (2014-11-22)
The magnetic properties of two similar Er(3+) complexes have been investigated. [Er(tpm)3(bipy)] (Htpm = 1,1,1-trifluoro-5,5-dimethyl-2,4-hexanedione and bipy = 2,2'-bipyridine) displays thermally activated slow relaxation of magnetisation under a zero direct-current (DC) field. Under an applied HDC field of 1000 G
Anne Baker et al.
Clinical rehabilitation, 31(1), 45-60 (2016-03-25)
To identify factors reported with negative and positive outcomes for caregivers of the traumatic brain injury and spinal cord injury cohorts, to investigate what interventions have been studied to support carers and to report what effectiveness has been found. Scoping
